1
|
Li W, Wang Z, Su Q, Chen J, Wu Q, Sun X, Zhu S, Li X, Wei H, Zeng J, Guo L, Zhang C, He J. A Reconfigurable DNA Framework Nanotube-Assisted Antiangiogenic Therapy. JACS Au 2024; 4:1345-1355. [PMID: 38665667 PMCID: PMC11040663 DOI: 10.1021/jacsau.3c00661] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/28/2023] [Revised: 02/28/2024] [Accepted: 03/15/2024] [Indexed: 04/28/2024]
Abstract
A major limitation of tumor antiangiogenic therapy is the pronounced off-target effect, which can lead to unavoidable injury in multiple organs. Ensuring sufficient delivery and controlled release of these antiangiogenic agents at tumor sites is crucial for realizing their clinical application. Here, we develop a smart DNA-based nanodrug, termed Endo-rDFN, by precisely assembling the antiangiogenic agent, endostar (Endo), into a reconfigurable DNA framework nanotube (rDFN) that could recognize tumor-overexpressed nucleolin to achieve the targeted delivery and controllable release of Endo. Endo-rDFN can not only effectively enhance the tumor-targeting capability of Endo and maintain its efficient accumulation in tumor tissues but also achieve on-demand release of Endo at tumor sites via the specific DNA aptamer for tumor-overexpressed nucleolin, named AS1411. We also found that Endo-rDFN exhibited significant inhibition of angiogenesis and tumor growth, while also providing effective protection against multiorgan injury (heart, liver, spleen, kidney, lung, etc.) to some extent, without compromising the function of these organs. Our study demonstrates that rDFN represents a promising vector for reducing antiangiogenic therapy-induced multiorgan injury, highlighting its potential for promoting the clinical application of antiangiogenic agents.
Collapse
Affiliation(s)
- Wei Li
- Department
of Oncology, Zhujiang Hospital, Southern
Medical University, Guangzhou, Guangdong 510282, China
- Department
of Endocrinology and Metabolism, 481 Center for Diabetes and Metabolism
Research, West China 482 Hospital, Sichuan
University, Chengdu 610041, China
| | - Zhongliang Wang
- Department
of Pathology, Zhujiang Hospital, Southern
Medical University, Guangzhou, Guangdong 510282, China
| | - Qing Su
- Department
of Pharmacy, Zhujiang Hospital, Southern
Medical University, Guangzhou, Guangdong 510282, China
| | - Jie Chen
- Department
of Radiation Oncology, Cancer Hospital of
Shantou University Medical College, Shantou, Guangdong 515000, China
| | - Qian Wu
- Department
of Pathology, Beijing Sixth Hospital, Beijing
University, Beijing 100080, China
| | - Xue Sun
- Department
of Pathology, Zhujiang Hospital, Southern
Medical University, Guangzhou, Guangdong 510282, China
| | - Shuhan Zhu
- Department
of Pathology, Zhujiang Hospital, Southern
Medical University, Guangzhou, Guangdong 510282, China
| | - Xiaodie Li
- Department
of Oncology, Zhujiang Hospital, Southern
Medical University, Guangzhou, Guangdong 510282, China
| | - Hao Wei
- Department
of Urology, Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, Shandong 266000, China
| | - Jialin Zeng
- Department
of Oncology, Zhujiang Hospital, Southern
Medical University, Guangzhou, Guangdong 510282, China
| | - Linlang Guo
- Department
of Pathology, Zhujiang Hospital, Southern
Medical University, Guangzhou, Guangdong 510282, China
| | - Chao Zhang
- Department
of Oncology, Zhujiang Hospital, Southern
Medical University, Guangzhou, Guangdong 510282, China
| | - Jian He
- Department
of Nuclear Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China
| |
Collapse
|
2
|
Zhao X, Guo Y, Li L, Li Y. Longitudinal change of serum inter-alpha-trypsin inhibitor heavy chain H4, and its correlation with inflammation, multiorgan injury, and death risk in sepsis. J Clin Lab Anal 2023; 37:e24834. [PMID: 36725250 PMCID: PMC9978082 DOI: 10.1002/jcla.24834] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2022] [Revised: 12/23/2022] [Accepted: 12/28/2022] [Indexed: 02/03/2023] Open
Abstract
BACKGROUND Inter-alpha-trypsin inhibitor heavy chain H4 (ITIH4) inhibits infection-induced inflammation and multiorgan injury through several methods. The present study aimed to estimate the association of serum ITIH4 with inflammatory cytokines, multiorgan injury, and death risk in sepsis patients. METHODS Serum samples were collected to detect ITIH4 by enzyme-linked immunosorbent assay in 127 sepsis patients at admission (baseline), day (D)1, D3, and D7 after admission, as well as in 30 healthy controls (HCs). Additionally, 28-day mortality was recorded in sepsis patients. RESULTS ITIH4 was reduced in sepsis patients versus HCs (median [interquartile range]: 147.9 [78.2-208.8] vs. 318.8 [237.2-511.4] ng/ml) (p < 0.001). In sepsis patients, ITIH4 was associated with the absence of cardiovascular and cerebrovascular disease history (p = 0.021). Additionally, ITIH4 was negatively correlated with tumor necrosis factor-α (p < 0.001), interleukin (IL)-1β (p < 0.001), IL-6 (p = 0.019), IL-17A (p = 0.002), and C-reactive protein (p = 0.001), but positively related to IL-10 (p = 0.007). Moreover, ITIH4 was also inversely associated with Acute Physiology and Chronic Health Evaluation II score (p = 0.002), Sequential Organ Failure Assessment (SOFA) score (p < 0.001), SOFA-respiratory system score (p = 0.023), and SOFA-renal system score (p = 0.007). Interestingly, ITIH4 gradually increased from baseline to D7 (p < 0.001); besides, ITIH4 at baseline (p = 0.009), D1 (p = 0.002), D3 (p < 0.001), and D7 (p = 0.015) were all decreased in sepsis deaths versus sepsis survivors. CONCLUSION Serum ITIH4 is raised from baseline to D7 after disease onset, and it reflects the reduction of systemic inflammation, disease severity, and 28-day mortality for sepsis. However, further verification is required.
Collapse
Affiliation(s)
- Xiangwang Zhao
- Department of Emergency Medicine, Shanghai East Hospital, Shanghai, China
| | - Yong Guo
- Department of Intensive Care Medicine, The Third People's Hospital, Qingdao, China
| | - Lingyu Li
- Department of Emergency Medicine, Shanghai East Hospital, Shanghai, China
| | - Yusheng Li
- Department of Emergency Medicine, Shanghai East Hospital, Shanghai, China
| |
Collapse
|
3
|
Ligi D, Maniscalco R, Plebani M, Lippi G, Mannello F. Do Circulating Histones Represent the Missing Link among COVID-19 Infection and Multiorgan Injuries, Microvascular Coagulopathy and Systemic Hyperinflammation? J Clin Med 2022; 11:jcm11071800. [PMID: 35407410 PMCID: PMC8999947 DOI: 10.3390/jcm11071800] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2022] [Revised: 03/21/2022] [Accepted: 03/23/2022] [Indexed: 02/07/2023] Open
Abstract
Several studies shed light on the interplay among inflammation, thrombosis, multi-organ failures and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Increasing levels of both free and/or circulating histones have been associated to coronavirus disease 2019 (COVID-19), enhancing the risk of heart attack and stroke with coagulopathy and systemic hyperinflammation. In this view, by considering both the biological and clinical rationale, circulating histones may be relevant as diagnostic biomarkers for stratifying COVID-19 patients at higher risk for viral sepsis, and as predictive laboratory medicine tool for targeted therapies.
Collapse
Affiliation(s)
- Daniela Ligi
- Unit of Clinical Biochemistry, Department of Biomolecular Sciences-DISB, University of Urbino Carlo Bo, 61029 Urbino, Italy
| | - Rosanna Maniscalco
- Unit of Clinical Biochemistry, Department of Biomolecular Sciences-DISB, University of Urbino Carlo Bo, 61029 Urbino, Italy
| | - Mario Plebani
- Department of Medicine-DIMED, University of Padua, 35128 Padua, Italy
| | - Giuseppe Lippi
- Section of Clinical Biochemistry, University Hospital of Verona, 37134 Verona, Italy
| | - Ferdinando Mannello
- Unit of Clinical Biochemistry, Department of Biomolecular Sciences-DISB, University of Urbino Carlo Bo, 61029 Urbino, Italy
| |
Collapse
|
4
|
Rakshit S, Nirala SK, Bhadauria M. Gallic Acid Protects from Acute Multiorgan Injury Induced by Lipopolysaccharide and D-galactosamine. Curr Pharm Biotechnol 2021; 21:1489-1504. [PMID: 32538720 DOI: 10.2174/1389201021666200615165732] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2019] [Revised: 03/30/2020] [Accepted: 03/31/2020] [Indexed: 12/12/2022]
Abstract
BACKGROUND Secondary metabolites of plants, the polyphenols, play a vital role in protection from many health problems in human beings. Structurally favored phytochemicals may be studied to protect multiorgan injury. At pharmacological doses, gallic acid is nontoxic to mammals and is generally absorbed in the intestine. AIMS In this present study, gallic acid was evaluated for its protective efficacy against Lipo Polysaccharide (LPS) and d-Galactosamine (D-GalN) induced multiorgan injury, i.e., liver, kidney and brain. METHODS Three different doses of gallic acid (5, 10 and 20 mg/kg p.o.) were administered to the experimental animals for 6 consecutive days, followed by exposure to LPS (50 μg/kg I.P.) and D-GalN (300 mg/kg I.P.) on the 6th day. RESULTS Exposure to LPS and D-GalN resulted in increased oxidative stress and proinflammatory cytokines. Altered hematology and serology due to LPS and D-GalN were restored towards control by gallic acid. Declined antioxidants such as reduced glutathione, superoxide dismutase and catalase due to injurious effects of LPS and D-GalN were rejuvenated by gallic acid. DISCUSSION Exposure to LPS and D-GalN severely increased lipid peroxidation, CYP2E1 activity and tissue lipids while lowered protein content. Gallic acid restored all these parameters towards control in dose dependent manner and 20 mg/kg dose provided the best protection. Histological study showed improved histoarchitecture of liver, kidney and brain that supported biochemical endpoints. CONCLUSION Gallic acid minimized oxidative stress and provided best protection at 20 mg/kg dose against LPS and D-GalN induced multi organ acute injury.
Collapse
Affiliation(s)
- Samrat Rakshit
- Toxicology and Pharmacology Laboratory, Department of Zoology Guru Ghasidas University, Bilaspur, 495009 (C.G.), India
| | - Satendra K Nirala
- Laboratory of Natural Products, Department of Rural Technology and Social Development Guru Ghasidas University, Bilaspur 495009 (C.G.), India
| | - Monika Bhadauria
- Toxicology and Pharmacology Laboratory, Department of Zoology Guru Ghasidas University, Bilaspur, 495009 (C.G.), India
| |
Collapse
|
5
|
Carlson FR, Bosukonda D, Keck PC, Carlson WD. Multiorgan Damage in Patients With COVID-19: Is the TGF- β/BMP Pathway the Missing Link? JACC Basic Transl Sci 2020; 5:1145-1148. [PMID: 32984657 PMCID: PMC7508496 DOI: 10.1016/j.jacbts.2020.09.003] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/14/2020] [Accepted: 09/14/2020] [Indexed: 01/13/2023]
Affiliation(s)
- F Roy Carlson
- Therapeutics by Design, LLC, Boston, Massachusetts, USA
| | - Dattatreyamurty Bosukonda
- Therapeutics by Design, LLC, Boston, Massachusetts, USA.,Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA
| | - Peter C Keck
- Therapeutics by Design, LLC, Boston, Massachusetts, USA
| | - William D Carlson
- Therapeutics by Design, LLC, Boston, Massachusetts, USA.,Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA.,Department of Medicine, Division of Cardiology, Harvard Medical School, Boston, Massachusetts, USA
| |
Collapse
|
6
|
Ditz I, Bizjak J. A Rare Case Report of the Use of Allium Stent in Management of a Gunshot Injury with Incomplete Tear of the Proximal Part of the Right Ureter. J Endourol Case Rep 2020; 5:154-156. [PMID: 32775651 DOI: 10.1089/cren.2019.0044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
Abstract
Background: Injuries to the ureter resulting from external trauma are uncommon. This type of injury is associated with a high mortality rate because of the involvement of concomitant multiorgan damage. Wound management depends primarily on the location and severity of the injury. In this study we present an example of Allium™ stent usage in a management of a rare type of injury with positive results. Case Presentation: The case involves a Caucasian man, 46 years of age, the victim of multiple gunshot injury. One bullet struck the abdomen and caused a multiple organ injury. The first surgery revealed a perforation of the duodenum and two perforations of the small bowel. On the second surgery, urea and creatinine were found in the excretion of abdominal drains. A CT scan identified an incomplete tear of the proximal part of the right ureter. The lesion was temporarily managed by insertion of a percutaneous nephrostomy. We decided to use an Allium stent for definitive delayed repair, because it should be ideal for long-term ureteral stenting and easy to remove. Conclusion: Because of the serious injuries and associated complications the patient had undergone three laparotomies and other surgical procedures. With the use of minimally invasive procedures we succeeded to repair the tear of the ureter. We demonstrate that the use of Allium stent is appropriate and safe in the management of ureteral injuries that result from penetrating trauma. The case also underlines the importance of careful examination for potential ureteral injuries after perforating external trauma.
Collapse
Affiliation(s)
- Iztok Ditz
- Department of Urology, Division of Surgery, University Medical Centre Ljubljana, Ljubljana, Slovenia
| | - Jure Bizjak
- Department of Urology, Division of Surgery, University Medical Centre Ljubljana, Ljubljana, Slovenia
| |
Collapse
|
7
|
Cornelius DC, Baik CH, Travis OK, White DL, Young CM, Austin Pierce W, Shields CA, Poudel B, Williams JM. NLRP3 inflammasome activation in platelets in response to sepsis. Physiol Rep 2020; 7:e14073. [PMID: 31054188 PMCID: PMC6499866 DOI: 10.14814/phy2.14073] [Citation(s) in RCA: 40] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2018] [Revised: 04/03/2019] [Accepted: 04/04/2019] [Indexed: 01/20/2023] Open
Abstract
Sepsis is a complex syndrome characterized by organ dysfunction and a dysregulated immune host response to infection. There is currently no effective treatment for sepsis, but platelets have been proposed as a potential therapeutic target for the treatment of sepsis. We hypothesized that the NLRP3 inflammasome is activated in platelets during sepsis and may be associated with multiorgan injury in response to polymicrobial sepsis. Polymicrobial sepsis was induced by cecal ligation and puncture (CLP) in 12‐ to 13‐week‐old male Sprague–Dawley rats. The necrotic cecum was removed at 24 h post‐CLP. At 72 h post‐CLP, activated platelets were significantly increased in CLP versus Sham rats. Colocalization of NLRP3 inflammasome components was observed in platelets from CLP rats at 72 h post‐CLP. Plasma, pulmonary, and renal levels of IL‐1β and IL‐18 were significantly higher in CLP rats compared to Sham controls. Soluble markers of endothelial permeability were increased in CLP versus Sham. Renal and pulmonary histopathology were markedly elevated in CLP rats compared to Sham controls. NLRP3 is activated in platelets in response to CLP and is associated with inflammation, endothelial permeability and multiorgan injury. Our results indicate that activated platelets may play a role to cause multiorgan injury in sepsis and may have therapeutic potential for the treatment of sepsis multiorgan injury.
Collapse
Affiliation(s)
- Denise C Cornelius
- Department of Emergency Medicine, University of Mississippi Medical Center, Jackson, Mississippi.,Department of Pharmacology, University of Mississippi Medical Center, Jackson, Mississippi.,Cardiovascular Renal-Research Center, University of Mississippi Medical Center, Jackson, Mississippi
| | - Cedar H Baik
- Department of Emergency Medicine, University of Mississippi Medical Center, Jackson, Mississippi
| | - Olivia K Travis
- Department of Pharmacology, University of Mississippi Medical Center, Jackson, Mississippi
| | - Dakota L White
- Department of Emergency Medicine, University of Mississippi Medical Center, Jackson, Mississippi
| | - Cassandra M Young
- Department of Pharmacology, University of Mississippi Medical Center, Jackson, Mississippi
| | - W Austin Pierce
- Department of Emergency Medicine, University of Mississippi Medical Center, Jackson, Mississippi
| | - Corbin A Shields
- Department of Pharmacology, University of Mississippi Medical Center, Jackson, Mississippi
| | - Bibek Poudel
- Department of Pharmacology, University of Mississippi Medical Center, Jackson, Mississippi
| | - Jan M Williams
- Department of Pharmacology, University of Mississippi Medical Center, Jackson, Mississippi.,Cardiovascular Renal-Research Center, University of Mississippi Medical Center, Jackson, Mississippi
| |
Collapse
|
8
|
Abstract
Hemorrhagic shock (HS) is associated with an excessive activation of inflammation, contributing to multiple organ failure in numerous medical or surgical conditions. To explore the therapeutic potential of crocin, a natural compound with anti-inflammatory properties, we administered crocin to rats during resuscitation following HS induced by withdrawing blood. Compared with control animals which were sham-treated, HS-operated rats showed organ damages as manifested by enhanced markers of multiple organ dysfunctions. Crocin treatment substantially reduced these parameters in rats subjected to HS, suggesting an alleviation of tissue injuries such as in the kidney, liver, pancreas, and muscle. The activation of NF-κB (nuclear factor κB) pathway in lung tissue by HS, as shown by increased nuclear translocation of p65 and IκBα phosphorylation, was diminished by crocin treatment. The crocin administration also significantly decreased the serum levels of proinflammatory cytokine TNF-α (tumor necrosis factor-α) and interleukin (IL)-6, whereas increased the level of anti-inflammatory cytokine IL-10 in HS-operated rats. These studies indicate that crocin administration may reduce inflammation-driven tissue damage in patients with HS.
Collapse
Affiliation(s)
- Long Yang
- 1 Department of Emergency, Cangzhou City Central Hospital Brain Campus , Cangzhou, China
| | - Xiujuan Dong
- 2 Department of Obstetrics, Cangzhou City Central Hospital , Cangzhou, China
| |
Collapse
|
9
|
Murugesan P, Jung B, Lee D, Khang G, Doods H, Wu D. Kinin B1 Receptor Inhibition With BI113823 Reduces Inflammatory Response, Mitigates Organ Injury, and Improves Survival Among Rats With Severe Sepsis. J Infect Dis 2015; 213:532-40. [PMID: 26310310 DOI: 10.1093/infdis/jiv426] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2015] [Accepted: 08/11/2015] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND This study examined the therapeutic effects of an orally active nonpeptide kinin B1 receptor antagonist, BI113823, in a clinically relevant experimental model of polymicrobial sepsis in rats. METHODS Sepsis was induced by cecal ligation and puncture (CLP). Animals received treatment with either vehicle or BI113823. The experiment was terminated in the first set of animals 15 hours after CLP. Seven-day survival following CLP was determined in the second set of animals. RESULTS Compared with vehicle treatment, administration of BI113823 reduced neutrophil and macrophage infiltration, reduced cytokine production, attenuated intestinal mucosal hyperpermeability, prevented hemodynamic derangement, and improved cardiac output. Furthermore, administration of BI113823 reduced inducible nitric oxide synthase expression and the injury score in the lung and attenuated nuclear factor ĸB activation and apoptosis in the liver. Treatment with BI113823 also reduced plasma levels of cardiac troponin, aspartate aminotransferase, alanine aminotransferase, urea, and lactate, as well as proteinuria. Finally, administration of BI113823 improved the 7-day survival rate following CLP in rats. CONCLUSIONS Administration of BI113823 reduced systemic and tissue inflammatory responses, prevented hemodynamic derangement, attenuated multiorgan injury, and improved overall survival.
Collapse
Affiliation(s)
- Priya Murugesan
- Department of BIN Fusion Technology, World Class University Program, Chonbuk National University, Jeonju, Korea
| | - Birgit Jung
- Respiratory Diseases Research, Boehringer Ingelheim Pharma, Biberach, Germany
| | - Dongwon Lee
- Department of BIN Fusion Technology, World Class University Program, Chonbuk National University, Jeonju, Korea
| | - Gilson Khang
- Department of BIN Fusion Technology, World Class University Program, Chonbuk National University, Jeonju, Korea
| | - Henri Doods
- Respiratory Diseases Research, Boehringer Ingelheim Pharma, Biberach, Germany
| | - Dongmei Wu
- Department of BIN Fusion Technology, World Class University Program, Chonbuk National University, Jeonju, Korea Department of Research, Mount Sinai Medical Center, Miami Beach, Florida
| |
Collapse
|